Volume 60, Issue 2, Pages (August 2011)

Slides:



Advertisements
Similar presentations
The PSA Era is not Over for Prostate Cancer
Advertisements

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017  Silke Gillessen, Gerhardt.
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Volume 70, Issue 1, Pages (July 2016)
Testosterone Therapy in Men With Prostate Cancer
David Lorente, Karim Fizazi, Christopher Sweeney, Johann S. de Bono 
Volume 69, Issue 5, Pages (May 2016)
Global Trends in Testicular Cancer Incidence and Mortality
Volume 68, Issue 6, Pages e129-e131 (December 2015)
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 61, Issue 6, Pages (June 2012)
Volume 73, Issue 2, Pages (February 2018)
Volume 68, Issue 4, Pages (October 2015)
Volume 66, Issue 5, Pages (November 2014)
Volume 74, Issue 2, Pages (August 2018)
Volume 64, Issue 4, Pages (October 2013)
Volume 69, Issue 5, Pages (May 2016)
Prostate Cancer Epidemic in Sight?
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration- resistant Prostate Cancer in the Era of Precision Oncology  Philipp.
Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer  Olav Erich Yri, Trine Bjoro, Sophie D.
Volume 71, Issue 2, Pages (February 2017)
Volume 72, Issue 5, Pages (November 2017)
Neeraj Agarwal, Guru Sonpavde, Cora N. Sternberg  European Urology 
Volume 68, Issue 4, Pages (October 2015)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 54, Issue 4, Pages (October 2008)
A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate.
Volume 65, Issue 1, Pages (January 2014)
Androgen Receptor Variants and Castration-resistant Prostate Cancer: Looking Back and Looking Forward  Takuma Uo, Cynthia Sprenger  European Urology 
The Potential of MicroRNAs as Prostate Cancer Biomarkers
Volume 71, Issue 1, Pages 1-3 (January 2017)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 70, Issue 4, Pages (October 2016)
Prostate Cancer Detection: A View of the Future
Volume 66, Issue 3, Pages (September 2014)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 66, Issue 5, Pages (November 2014)
Volume 69, Issue 3, Pages (March 2016)
Volume 73, Issue 6, Pages (June 2018)
Volume 70, Issue 1, Pages (July 2016)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 70, Issue 1, Pages e27-e28 (July 2016)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 72, Issue 1, Pages (July 2017)
Volume 66, Issue 2, Pages (August 2014)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.
Volume 71, Issue 2, Pages (February 2017)
Volume 50, Issue 5, Pages (November 2006)
Volume 53, Issue 6, Pages (June 2008)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Volume 73, Issue 5, Pages (May 2018)
Testicular Cancer Variations in Time and Space in Europe
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Volume 71, Issue 4, Pages (April 2017)
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
European Urology Oncology
Volume 53, Issue 6, Pages (June 2008)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 60, Issue 2, Pages 279-290 (August 2011) New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety  Himisha Beltran, Tomasz M. Beer, Michael A. Carducci, Johann de Bono, Martin Gleave, Maha Hussain, William K. Kelly, Fred Saad, Cora Sternberg, Scott T. Tagawa, Ian F. Tannock  European Urology  Volume 60, Issue 2, Pages 279-290 (August 2011) DOI: 10.1016/j.eururo.2011.04.038 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Landscape of castration-resistant prostate cancer. AR = androgen receptor. European Urology 2011 60, 279-290DOI: (10.1016/j.eururo.2011.04.038) Copyright © 2011 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.